前往化源商城

3-[3-(氯甲基)苯基]-1-甲基-1H-吡唑

更新时间:2025-08-25 11:50:34

3-[3-(氯甲基)苯基]-1-甲基-1H-吡唑结构式
3-[3-(氯甲基)苯基]-1-甲基-1H-吡唑结构式
品牌特惠专场
常用名 3-[3-(氯甲基)苯基]-1-甲基-1H-吡唑 英文名 3-[3-(Chloromethyl)Phenyl]-1-methyl-1H-pyrazole
CAS号 912569-61-0 分子量 206.67100
密度 1.17g/cm3 沸点 338.1ºC at 760 mmHg
分子式 C11H11ClN2 熔点 N/A
MSDS N/A 闪点 158.3ºC

 3-[3-(氯甲基)苯基]-1-甲基-1H-吡唑名称

中文名 3-(1-甲基-3-吡唑)苄氯
英文名 3-[3-(chloromethyl)phenyl]-1-methylpyrazole
中文别名 3-[3-(氯甲基)苯基]-1-甲基-1H-吡唑
英文别名 更多

 3-[3-(氯甲基)苯基]-1-甲基-1H-吡唑物理化学性质

密度 1.17g/cm3
沸点 338.1ºC at 760 mmHg
分子式 C11H11ClN2
分子量 206.67100
闪点 158.3ºC
精确质量 206.06100
PSA 17.82000
LogP 2.82590
折射率 1.589
储存条件 室温, 密封, 干燥, 惰性气体

 3-[3-(氯甲基)苯基]-1-甲基-1H-吡唑安全信息

危害码 (欧洲) C
海关编码 2933199090

 3-[3-(氯甲基)苯基]-1-甲基-1H-吡唑海关

海关编码 2933199090
中文概述 2933199090. 其他结构上有非稠合吡唑环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
Summary 2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 3-[3-(氯甲基)苯基]-1-甲基-1H-吡唑英文别名

MFCD09702402
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
推荐供应商:

暂无推荐供应商。我要出现这里

相关化合物: 更多...
3-(4-(氯甲基)苯基)-1-甲基-1H-吡唑
916766-83-1
3-(3-甲氧基苯基)-1-甲基-1H-吡唑-5-羧酸
1022575-47-8
3-(氯甲基)-5-(2-呋喃基)-1-甲基-1H-吡唑
876316-48-2
4-(4-(氨基甲基)-3-甲基苯基)-N-(1-甲基-1H-吡唑-4-基)嘧啶-2-胺盐酸盐
1798791-46-4
3-(4-甲氧基苯基)-1-甲基-1H-吡唑-5-醇
1202873-63-9
3-(4-甲氧基苯基)-1-甲基-1H-吡唑-5-羧酸
93618-34-9
3-(4-甲氧基苯基)-1-甲基-1H-吡唑-5-羧酸乙酯
618070-51-2
1-(4-(氯甲基)苯基)-3-甲基-1H-吡唑
1248072-48-1
5-(3,4-二甲氧基苯基)-1-甲基-1H-吡唑-4-胺
765286-75-7
3-Oxazolidinepentanoic acid,-[(S)-[(4-fluorophenyl)amino][4-(2-propen-1-yloxy)phenyl]methyl]-,2-dioxo-4-phenyl-, phenylmethyl ester, (R,4S)-
1202579-22-3
4-O-tert-butyl 1-O-[(3R,5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanedioate
1202710-63-1
[1,1'-Biphenyl]-4-propanoic acid,-(acetylamino)-, (R)-, compd. with (S)--methylbenzenemethanamine (1:1)
1236479-65-4
tert-butyl N-[(2S)-1-[[(1S)-2-[(2S)-2-carbamoyl-3-[(1S,2R)-2-[6-[[(1S,2R)-1-[(2S)-2-carbamoyl-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propanoyl]amino]acetyl]pyrrolidin-3-yl]-2,3-dihydro-1H-inden-2-yl]oxy]hexa-2,4-diynoxy]-2,3-dihydro-1H-inden-1-yl]pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]amino]-1-oxopropan-2-yl]-N-methylcarbamate
1258392-64-1
[4-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]amino]phenyl]methyl (6S,6aS)-3-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylate
1343476-22-1
methyl 2-(3-aminopropoxy)-4-[(E)-3-(3,5-ditert-butylphenyl)-3-oxoprop-1-enyl]benzoate;hydrochloride
1351169-37-3
H-Asn-Leu-Gly-Val-Cys(Acm)-NH2
136467-00-0
[(2R,3R,4R,5R)-5-(6-benzamidopurin-9-yl)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxyoxolan-3-yl] 2-cyanoethyl prop-2-enyl phosphate
1427449-37-3
[(2R,3R,4R,5R)-5-(6-benzamidopurin-9-yl)-2-[[[(2R,3R,4R,5R)-5-(6-benzamidopurin-9-yl)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxyoxolan-3-yl]oxy-(2-cyanoethoxy)phosphoryl]oxymethyl]-4-[tert-butyl(dimethyl)silyl]oxyoxolan-3-yl] 2-cyanoethyl prop-2-enyl phosphate
1427449-39-5
D-Glucose, 2-deoxy-6-O-[2-deoxy-2-[[1-oxo-3-[(1-oxododecyl)oxy]tetradecyl]amino]-3-O-[1-oxo-3-[(1-oxotetradecyl)oxy]tetradecyl]-4-O-phosphono--D-glucopyranosyl]-2-[[1-oxo-3-[(1-oxohexadecyl)oxy]tetradecyl]amino]-
147219-31-6